Generic Name |
Autologous TIL + IL-2 | |
|---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
||
Drug Type |
Immunotherapy | |
Delivery |
Intravenous | |
Approval Status |
||
Indications |
||
Overall Strategy |
Immunotherapy | |
Strategy |
Stimulate the immune system | |
Drug Category |
Immunotherapy | |
Links |
|
Trials of this drug |
|
|
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors |
Trial results |
|